About the Company
We do not have any company description for iTeos Therapeutics, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on iTeos Therapeutics, Inc.
Is iTeos Therapeutics, Inc.'s (NASDAQ:ITOS) Latest Stock Performance A ...
iTeos Therapeutics' (NASDAQ:ITOS) stock is up by a considerable 23% over the past three months. Since the market usually pay for a company’s long-term fundamentals, we decided to study the ...
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Third-Quarter Results Just Came ...
Last week, you might have seen that iTeos Therapeutics, Inc. (NASDAQ:ITOS) released its third-quarter result to the market. The early response was not positive, with shares down 7.8% to US$8.46 in ...
Positive week for iTeos Therapeutics, Inc. (NASDAQ:ITOS) institutional ...
If you want to know who really controls iTeos Therapeutics, Inc. (NASDAQ:ITOS), then you'll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie ...
iTeos Therapeutics Inc. Company & People | ITOS | Barron's
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with ...
iTeos Therapeutics Inc. Stock Grades | ITOS | Barron's
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with ...
iTeos Therapeutics Announces New Preliminary Data Indicating Clinical ...
About iTeos Therapeutics, Inc. iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno ...
iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 ...
The ESMO website indicates that all late-breaking abstracts will be published on the ESMO website on the day of the presentation at 00:05 am CEST. About iTeos Therapeutics, Inc.
iTeos Therapeutics Inc.: iTeos Therapeutics Announces Its Intention to ...
WATERTOWN, Mass. and GOSSELIES, Belgium, May 28, 2025 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and ...
Similar Companies
Loading the latest forecasts...